Artesunate
Artesunate is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
- Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
- Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Mild to moderate malaria falciparum.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
- Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
- Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Mild to moderate malaria falciparum.
There's more to see -- the rest of this entry is available only to subscribers.